Published in Phys Med Biol on August 01, 1997
Characterization of a new radiochromic three-dimensional dosimeter. Med Phys (2006) 3.46
A practical three-dimensional dosimetry system for radiation therapy. Med Phys (2006) 2.68
Dynamics of paramagnetic agents by off-resonance rotating frame technique in the presence of magnetization transfer effect. J Magn Reson (2006) 0.77
Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea (1997) 1.48
Magnetic resonance imaging (MRI) and model-free estimates of brain volume determined using the Cavalieri principle. J Anat (1991) 1.33
Long-term renal function after treatment for malignant germ-cell tumours. Ann Oncol (2002) 1.28
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol (2010) 1.17
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys (1999) 1.15
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer (1996) 1.15
Cloning of full-length elastin cDNAs from a human skin fibroblast recombinant cDNA library: further elucidation of alternative splicing utilizing exon-specific oligonucleotides. J Invest Dermatol (1988) 1.07
Cancer treatment by radiotherapy in Western Nepal: a hospital-based study. Asian Pac J Cancer Prev (2009) 1.05
Molecular mechanisms of cutaneous aging. Age-associated connective tissue alterations in the dermis. J Am Acad Dermatol (1989) 1.04
Expression of eukaryotic proteins in soluble form in Escherichia coli. Protein Expr Purif (1998) 1.04
Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol (2001) 1.04
Transforming growth factor-beta up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Invest (1992) 1.02
Extracellular matrix of the skin: 50 years of progress. J Invest Dermatol (1989) 1.01
Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res (1992) 1.01
Sensitivity and stability of LiF thermoluminescence dosimeters. Med Dosim (1995) 0.98
Production of recombinant human type I procollagen trimers using a four-gene expression system in the yeast Saccharomyces cerevisiae. J Biol Chem (2000) 0.98
Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture. Biochem Biophys Res Commun (1991) 0.94
Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med (1989) 0.92
Human nidogen: complete amino acid sequence and structural domains deduced from cDNAs, and evidence for polymorphism of the gene. DNA (1989) 0.91
Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study. Radiat Oncol (2011) 0.90
Isolation and characterization of human elastin cDNAs, and age-associated variation in elastin gene expression in cultured skin fibroblasts. Lab Invest (1988) 0.88
Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix. Int J Radiat Oncol Biol Phys (2000) 0.88
Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging. Magn Reson Med (1998) 0.87
External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys (1997) 0.85
Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts. Br J Cancer (1987) 0.85
Measurement of the extracellular volume of human melanoma xenografts by contrast enhanced magnetic resonance imaging. Magn Reson Imaging (2000) 0.84
Methods for fully automated verification of patient set-up in external beam radiotherapy with polygon shaped fields. Phys Med Biol (1994) 0.84
Skin aging: lessons from cutis laxa and elastoderma. Cutis (1989) 0.83
Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach. Acta Oncol (1996) 0.83
Reduction in dose from CT examinations of liver lesions with a new postprocessing filter: a ROC phantom study. Acta Radiol (2008) 0.82
De Barsy syndrome: report of a case, literature review, and elastin gene expression studies of the skin. Am J Med Genet (1992) 0.82
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer (1993) 0.82
Relationship between sharpness and noise in CT images reconstructed with different kernels. Radiat Prot Dosimetry (2010) 0.81
Intra-operative irradiation (IORT) for primary advanced and recurrent rectal cancer. a need for randomised studies. Eur J Cancer (2000) 0.81
Dose distribution measurements by MRI of a phantom containing lung tissue equivalent compartments made of ferrous sulphate gel. Phys Med Biol (2000) 0.81
Consequences of leaf calibration errors on IMRT delivery. Phys Med Biol (2007) 0.81
Extracellular matrix gene expression by human endothelial and smooth muscle cells. Matrix (1991) 0.80
Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry. Int J Radiat Biol (2000) 0.79
Whole-body distribution of radioactivity after intraperitoneal administration of 32P colloids. Br J Radiol (1984) 0.79
Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys (1999) 0.79
[The radiotherapy satellite in Kristiansand--a model for Norwegian regional hospitals?]. Tidsskr Nor Laegeforen (2001) 0.79
Proton relaxation times and interstitial fluid pressure in human melanoma xenografts. Br J Cancer (1997) 0.79
Expression of extracellular matrix genes by cultured human cells: localization of messenger RNAs and antigenic epitopes. Anal Biochem (1989) 0.79
Comparative analyses of the dynamic properties of the bladder wall studied by repetitive pelvic CT scans of patients and cryo-sections of cadavers. Br J Radiol (2005) 0.78
An anthropomorphic phantom for receiver operating characteristic studies in CT imaging of liver lesions. Br J Radiol (1999) 0.78
Comparative analyses of the dynamic properties of the rectum studied by cryo-sections of human cadavers and pelvic CT scans of patients. Br J Radiol (2003) 0.78
Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP). Clin Cancer Res (1999) 0.77
Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiother Oncol (1997) 0.77
Methods for automatic detection of peristaltic waves in the small intestine. Eur J Nucl Med (1998) 0.77
Measurement of dose rate at the interface of cell culture medium and glass dishes by means of ESR dosimetry using thin films of alanine. Radiat Res (1999) 0.76
Transforming growth factor-beta up-regulates the expression of the genes for beta 4 integrin and bullous pemphigoid antigens (BPAG1 and BPAG2) in normal and transformed human keratinocytes. J Invest Dermatol (1992) 0.76
Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. Br J Cancer (2003) 0.76
Differential extracellular matrix gene expression by fibroblasts during their proliferative life span in vitro and at senescence. J Cell Physiol (1992) 0.76
Preparation of a radionuclide/gel formulation for localised radiotherapy to a wide range of organs and tissues. Pharmazie (2006) 0.76
31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. Br J Cancer (1993) 0.76
Comparison of radiation side-effects in prostate cancer. Lancet (1999) 0.75
Inverse dose-rate effect due to pre-mitotic accumulation during continuous low dose-rate irradiation of cervix carcinoma cells. Int J Radiat Biol (1999) 0.75
Regarding, Ting, IJROBP 38(5):1105-1111. Int J Radiat Oncol Biol Phys (1998) 0.75
A computer algorithm for triple radionuclide subtraction studies applied for preoperative localization of enlarged parathyroid glands. Eur J Nucl Med (1977) 0.75
Assessment of image quality and total performance in Norwegian mammography laboratories. Findings in a national survey based on different phantoms and ROC methodology. Acta Radiol (1998) 0.75
Specification of the dose to organs at risk in external beam radiotherapy. Acta Oncol (1997) 0.75
[The HIV epidemic--concealed figures among intravenous drug abusers]. Tidsskr Nor Laegeforen (1988) 0.75
Radiotherapy in Scandinavia. Acta Oncol (1998) 0.75
The Norwegian injection mark study. Br J Addict (1989) 0.75
Migration of 99mTc-labelled syngeneic lymphocytes in the rat. Biological and theoretical models predict radiation damage and poor scintigraphic detectability. J Immunol Methods (1990) 0.75
Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel. Radiother Oncol (1997) 0.75
[The concealed figures of the HIV epidemic]. Tidsskr Nor Laegeforen (1988) 0.75
31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation. NMR Biomed (1995) 0.75
Non-invasive assessment of tumor oxygenation status by integrated 31P NMR spectroscopy and 1H NMR imaging. Adv Exp Med Biol (1994) 0.75
Methods for separation of contributions from two radionuclides in autoradiography with a silicon strip detector. Phys Med Biol (2000) 0.75
Evaluation of labelled monoclonal antibodies by simultaneous estimation of the association constant, the immunoreactive fraction, and the number of effective binding sites on the specific target. J Immunol Methods (1992) 0.75
[Are the Norwegian nuclear medicine laboratories good enough? A report from a nationwide quality control survey of nuclear medicine instruments performed by the Norwegian Society for Nuclear Medicine and the National Institute for Radiation Protection]. Tidsskr Nor Laegeforen (1985) 0.75
[Measurement of glomerular filtration rate in connection with 99Tc-DTPA renography]. Tidsskr Nor Laegeforen (1999) 0.75
Absorbed dose resulting from a specially designed computed tomography technique for examination of the urinary bladder. Acta Radiol (1989) 0.75
Exogenous transforming growth factor-beta(2) enhances connective tissue formation in transforming growth factor-beta(1)-deficient, healing-impaired dermal wounds in mice. Wound Repair Regen (1993) 0.75
An iterative computer algorithm for optimization of radionuclide subtraction studies. Phys Med Biol (1975) 0.75
Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomography. Eur J Nucl Med (1986) 0.75
Measurement of dynamic wedge angles and beam profiles by means of MRI ferrous sulphate gel dosimetry. Phys Med Biol (1996) 0.75
Clinical results with 131I-toluidine blue and triple radionuclide subtraction for preoperative localization of enlarged parathyroid glands. Eur J Nucl Med (1978) 0.75
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular bone. Phys Med Biol (2001) 0.75
Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals. Nucl Med Commun (1998) 0.75
An examination of different mathematical models for renal function as measured by 131I-hippuran renography. Med Phys (1975) 0.75
A mathematical model for the liver uptake and excretion of 99mTc-diethyl IDA. Eur J Nucl Med (1981) 0.75
A simple method for localization and shielding of organs in diverging radiation treatment beam. Br J Radiol (1980) 0.75
Uptake and localization of 131I-labeled anti-calcitonin immunoglobulins in rat medullary thyroid carcinoma tissue. Cancer (1982) 0.75
[The depressive statistics of the HIV epidemic]. Tidsskr Nor Laegeforen (1988) 0.75
Combined modality treatment including IORT in locally advanced and recurrent rectal cancer: results from a prospective Norwegian study. Front Radiat Ther Oncol (1997) 0.75
Detectability of simulated masses and calcifications in mammography. Development of a phantom and a new method for determination of receiver operating characteristics. Acta Radiol (1998) 0.75
Immunoscintigraphy of bone sarcomas--results in 5 patients. Eur J Cancer (1994) 0.75
[Radiotherapy of skeletal metastases]. Tidsskr Nor Laegeforen (2000) 0.75
Lymphatic drainage from subcutaneous tissue in the foot and leg in the sitting human. Acta Physiol Scand (1985) 0.75
Development of an experimental model for high dose rate endocavitary irradiation of the rat rectum. Br J Radiol (1996) 0.75